Generate Biomedicines

US · GENB #2875 by market cap Listed 2026

13.57 -0.23 -1.67%

Live - 5344 symbols - heartbeat 558s ago · 2026-10-08 08:03

Pre-market 13.44 -0.96%

After-hours 13.57 0.00%

Overnight 13.71 +1.03%

Market cap: 1.74B
P/E (TTM): -6.48
P/B: 3.82
EPS: -1.96
Div yield: 0.00%
52W pos: 22%

Reader sentiment Are you bullish or bearish on GENB?

Anonymous reader poll. Unscientific, not investment advice.

About Generate Biomedicines

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Founded: 2018
CEO: Mr. Michael Nally
Employees: 312
Headquarters: Somerville, Massachusetts, United States of America
Fiscal year end: 12-31
Website: generatebiomedicines.com

Company profile

Exchange: US
Symbol: GENB
Market-cap rank: #2875
Listing date: 2026-02-27
Market cap: 1.74B
Float cap: 820.30M
Shares out: 128.35M
Float shares: 60.45M

Sectors & themes

Biotechnology NVIDIA Portfolio IPOs

Browse all sectors & themes

Quote time 2026-10-08 08:03:29 · For reference only, not investment advice and not tailored to your situation.